Neoplasms, Mesothelial  >>  epirubicin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00017186: Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Completed
2
69
US
epirubicin hydrochloride, gemcitabine hydrochloride
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Malignant Mesothelioma
08/04
05/08

Download Options